India’s organised pet healthcare space continues to gain momentum as Bengaluru-based startup Dr. Doodley has raised $3.3 million (around ₹30 crore) in a pre-Series A funding round. The fundraise includes ₹20 crore in equity and ₹10 crore in debt, with the equity portion led by V3 Ventures.
The round also saw participation from Campus Fund and Thackersey Family Office, along with a group of angel investors including Yatin Shah and Karan Bhagat of 360 ONE Wealth, and Gautam Dalmia, managing director of Dalmia Bharat Group.
Founded in 2023 by Utsav Bisaria and Yash Jayprakash Ladda, Dr. Doodley operates a hybrid pet care model combining vet-at-home services with 24/7 multispecialty pet hospitals. The startup currently runs three hospitals in Bengaluru Jayanagar, Yelahanka, and Whitefield and works with a team of nearly 35 veterinarians.
The fresh capital will be used to expand hospital infrastructure, strengthen clinical operations, and support entry into additional tier-I cities. Over the next year, Dr. Doodley plans to scale to seven hospitals by opening four new facilities across Bellandur, Indiranagar, Rajajinagar, and North Bengaluru.
As part of its growth roadmap, the company aims to treat more than one lakh pets, expand its veterinary workforce to over 100 doctors, and roll out 30-minute vet-at-home services. It also plans to introduce a flat ₹10,000 pricing model for surgeries, aimed at improving affordability and transparency in pet healthcare.
Dr. Doodley claims to have already treated over 30,000 pets and conducted more than 1,000 surgeries in the past year, indicating strong demand for organised veterinary services in urban markets.
With rising pet adoption and increasing spending on animal health, India’s pet care industry is seeing a shift toward professionally managed platforms. Dr. Doodley’s latest fundraise positions it to scale operations and build a differentiated, full-stack pet healthcare network in a largely fragmented market.
Follow Startupbydoc for daily startup insights, funding news, IPO analysis, and business breakdowns.